SABER Study for Selected Early Stage Breast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age50+
SponsorUniversity of Miami
About this trial
The purpose of this study is to find the most effective dose of radiation therapy to give to breast tumors in a shorter period of time, prior to standard partial mastectomy/axillary surgery.
Eligibility criteria
Qualifiers
Female, ≥ 50 years of age.
Oncotype or MammaPrint diagnosis results are required prior to the start of treatment
Histologically confirmed invasive breast cancer.
Clinical stage T1N0M0.
Disqualifiers
Patients without histologically confirmed invasive breast cancer.
Patients without Oncotype or MammaPrint diagnosis results at the start of treatment.
Patients with metastatic disease.
ECOG 2, 3, 4.
Trial design
Treatments tested in this trial
- Stereotactic Ablative Breast Radiotherapy
Treatment groups
18 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov